A Novartis drug approved as a second-line treatment for a blood disorder snagged the FDA's Breakthrough Therapy Designation as a first-line defense. Source: BioSpace

The additional capital is expected to provide funding to advance avacopan through topline data from the Phase III ADVOCATE trial as well as potential registration filings in the U.S. and…

The Series A round was entirely funded by founding investor Apple Tree Partners. Source: BioSpace

Dr. Lammers brings more than 27 years of experience in product and clinical development spanning the pharmaceutical and biotechnology industries. Source: BioSpace

Prelude Fertility was founded in late 2016 by successful startup entrepreneur Martin Varsavsky with a $200M investment. Source: BioSpace

The Company previously completed a seed round fundraising in 2008 concurrent with its founding. Source: BioSpace

Pfizer will use Arvinas' proprietary PROTAC Platform to create small molecule therapeutics aimed at degrading disease-causing cellular proteins. Source: BioSpace

The therapy is the first type approved by the FDA that targets a disease caused by mutations in a specific gene. Source: BioSpace

The company said the Breakthrough Therapy Designation is based on positive results from the Phase III MONALEESA-7 trial. Source: BioSpace

Indivior today announced that Indivior UK Limited has entered into a strategic collaboration with Addex, in the field of GABAB PAMs. Source: BioSpace